Jumped into SNSS
at this low signal of 4.24. This drop
in share price occurred after recent earnings
report on March 8th. This is a psychological pitfall, expecting shares to jump back between the middle and bottom Bands by mid week.
The company reported $0.21 earnings
per share for the quarter
has a 52 week low of $1.82 and a 52 week high of $7.69.
Among 5 analysts covering Sunesis Pharmaceuticals
, 2 have Buy rating, 1 Sell and 2 Hold.